BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18492607)

  • 1. Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint.
    Wu XY; Qian JJ; Lin Y; Zheng MH
    Eur J Cancer; 2008 Jul; 44(11):1596-602. PubMed ID: 18492607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular functions and biological roles of hepatitis B virus x protein.
    Tang H; Oishi N; Kaneko S; Murakami S
    Cancer Sci; 2006 Oct; 97(10):977-83. PubMed ID: 16984372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.
    Pichierri P; Rosselli F
    EMBO J; 2004 Mar; 23(5):1178-87. PubMed ID: 14988723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hepatitis B virus X protein on the development of liver cancer.
    Zhang X; Zhang H; Ye L
    J Lab Clin Med; 2006 Feb; 147(2):58-66. PubMed ID: 16459163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
    Guervilly JH; Macé-Aimé G; Rosselli F
    Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1.
    Martin-Lluesma S; Schaeffer C; Robert EI; van Breugel PC; Leupin O; Hantz O; Strubin M
    Hepatology; 2008 Nov; 48(5):1467-76. PubMed ID: 18781669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
    Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
    PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
    Joo HY; Han KH; Ryu WS
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.
    Sze KM; Chu GK; Lee JM; Ng IO
    Hepatology; 2013 Jan; 57(1):131-9. PubMed ID: 22821423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
    Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
    J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
    Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
    Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
    Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
    Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
    Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line.
    Zhao X; Zhao Z; Guo J; Huang P; Zhu X; Zhou X; Yang Z; Zhao L; Xu L; Xu J; Fu L; Zhang J; Zhang X; Dong Y; Huang G; Wang Q; Li B; Song X; Yang X; Liu S; Yi S; Yu T; Yu C; Hou L; Li J; Chen W
    J Biomol Screen; 2013 Apr; 18(4):378-87. PubMed ID: 23042077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
    Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.